Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy USA is fulfilling its ambition of establishing a leading brand-focused cannabis company concentrated on state-legal markets and hemp-derived products across the U.S. SMITHS FALLS, ON , Oct. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today confirmed that Canopy USA, LLC ("Canopy USA") has completed its acquisition of Wana (as defined below), inclusive of Wana Wellness, LLC, The CIMA Group, LLC, and Mountain High Products, LLC (collectively, "Wana"). Canopy USA now owns 100% of the outstanding equity interests in Wana.

Canopy Growth Confirms Canopy USA's Acquisition of Wana

Cronos Group

Tilray Brands

For most of the campaign cycle, those bullish on cannabis stocks viewed a Vice President Kamala Harris presidency as the most beneficial to the sector.

3 Cannabis Stocks to Monitor as the Election Approaches

With most marijuana stocks still showing volatile trading is now the time to buy? Well, it's not such an easy answer as some may find the volatile behavior of marijuana stocks to be in their favor. The cannabis sector has been showing a large amount of volatility for some time. What this means is the slightest factor can impact how the better part of the sector trades. Often leading to a downtrend for most marijuana stocks until such time there is a means to see a recovery.

These Canadian Marijuana Stocks Could Be The Winners You Need

Aurora Cannabis

AdvisorShares Pure US Cannabis ETF

The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at times, a volatile market.

Profit from the Green Wave: Top Cannabis Stocks to Watch

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

The latest trading day saw Canopy Growth Corporation (CGC) settling at $4.57, representing a +1.11% change from its previous close.

Why the Market Dipped But Canopy Growth Corporation (CGC) Gained Today

SMITHS FALLS, ON , Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting").

Canopy Growth Announces Results of Annual General Meeting

Canopy Growth Corporation (CGC) reachead $4.64 at the closing of the latest trading day, reflecting a -1.49% change compared to its last close.

Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today

Shareholders now have until September 24, 2024 at 9:00 a.m. (Eastern Time) to submit votes to help ensure a quorum is achieved Your Vote is Important!

Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General Meeting

The Canadian cannabis market remains a focal point for investors this week, especially with companies expanding into the U.S. market. Recently, the U.S. cannabis industry has shown remarkable growth, with sales projected to reach $45 billion by 2025. This expansion offers Canadian companies a gateway to a larger consumer base. The increasing push for legalization in the U.S. is also a significant factor. States are continuously passing legislation to legalize cannabis for recreational and medicinal use. Therefore, investors watch how Canadian stocks position themselves for potential U.S. market entry.

Canadian Cannabis Stocks Set to Soar Right Now

Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline on September 20, 2024 at 1:00 p.m. (Eastern time) Company Releases Q&A About Annual Meeting Quorum Your Vote is Important!

Canopy Growth Urges Shareholders to Cast their Vote for the Upcoming Annual Meeting Today

Shares of Canopy Growth (CGC), Tilray Brands (TLRY), and other cannabis providers surged in intraday trading Monday after former President Donald Trump signaled his support for reducing restrictions on marijuana use.

Cannabis Stocks Get Boost as Trump Backs Easing Restrictions

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Trulieve Cannabis Corp.

GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.

Cannabis stocks rally after Trump supports moving drug to less restrictive category

The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Village Farms International

Investors looking to capitalize on the growing cannabis market should watch top Canadian marijuana stocks this week. With the US cannabis industry projected to reach $41 billion by 2025, many Canadian companies are expanding their presence across the border. This expansion is driven by increasing legalization efforts and growing consumer demand. For example, recent news highlights the potential for federal legalization in the US, which could open up significant opportunities for Canadian companies. Investors should utilize technical analysis and proper risk management strategies to navigate this dynamic market. Analyzing price trends, volume, and support levels can provide valuable insights into potential stock movements.

Best Canadian Cannabis Stocks to Watch in September

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

Switch to Vaporizing and Try the VENTY TUTTLINGEN, Germany , Aug. 29, 2024 /PRNewswire/ - STORZ & BICKEL GmbH (" STORZ & BICKEL "), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), today announced the launch of a new inaugural campaign, the Smokeless September Challenge. This initiative invites consumers to take a break from combustion throughout September and experience the advantages of vaporizing with STORZ & BICKEL's latest device, the VENTY.

STORZ & BICKEL Debuts Inaugural "Smokeless September Challenge" to Educate Consumers on the Advantages of Vaporization

Cannabis stocks have crashed hard this year as concerns about the industry continued. The AdvisorShares Pure US Cannabis ETF (MSOS) stock has plunged by almost 14% this year and is down by over 46% from its highest point this year.

Here's why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed

Canopy Growth CEO David Klein will retire at the end of the company's current fiscal year. While he has helped bring down expenses, profitability remains a big problem for the business.

Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?

Cannabis stocks slumped Tuesday after the Drug Enforcement Administration (DEA) announced a hearing that could reclassify marijuana as a less harmful, Schedule III drug won't come until Dec. 2—after the 2024 presidential election.

Cannabis Stocks Slide as DEA Sets Post-Election Marijuana Hearing in December

The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.

3 Weed Stocks Sinking on Reclassification Hearing Update

SNDL Inc.

The Canadian cannabis sector continues attracting attention from investors, especially as the US market shows promising growth. With over 39 states having legalized cannabis in some form, the US cannabis industry is projected to reach $100 billion by 2030. This rapid expansion presents a unique opportunity for Canadian companies with significant US operations. Recently, headlines have highlighted the push for federal legalization in the US, sparking renewed interest in marijuana stocks. Investors are mainly focused on Canadian companies, as they are well-positioned to capitalize on any positive legislative changes in the US.

Top Canadian Cannabis Stocks to Watch Before September

Aurora Cannabis and Canopy Growth have been leading companies within the cannabis industry for years. Both businesses have struggled, however, and have been working on improving their financials.

Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years

The Canadian cannabis market continues to play a pivotal role in the North American cannabis industry. As US cannabis laws evolve, Canadian companies are well-positioned to capitalize on this growth. The US cannabis industry is expected to reach $45.9 billion by 2025, driven by increased legalization and consumer demand. Recent headlines have highlighted ongoing discussions in Congress about federal legalization, which could be a game-changer. With more states moving toward legalization, the market is ripe for expansion. Canadian cannabis stocks are gaining attention as investors look for opportunities in this growing sector. These stocks offer exposure to the Canadian market and the potential US boom.

Top Canadian Cannabis Stocks to Watch Now: High-Growth Opportunities in 2024

What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by day.

News for Canopy Growth Stock (CGC)